{"id":200,"date":"2023-03-10T11:14:19","date_gmt":"2023-03-10T10:14:19","guid":{"rendered":"https:\/\/immunoregister.de\/home\/"},"modified":"2023-04-04T14:11:19","modified_gmt":"2023-04-04T12:11:19","slug":"home","status":"publish","type":"page","link":"https:\/\/immunoregister.de\/en\/","title":{"rendered":"Home"},"content":{"rendered":"
<\/div><\/div><\/div>
[vc_custom_heading text=”ImmunoRegister gUG” font_container=”tag:h1|text_align:center” use_theme_fonts=”yes”]<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
[vc_custom_heading text=”Background” use_theme_fonts=”yes”]

ImmunoRegister gUG is a non-profit company. Its purpose is the promotion of public health and science and research. The focus is on epidemiological and clinical research of inflammatory bowel diseases.<\/p>\n

For this purpose, ImmunoRegister gUG operates a prospective national and multicenter long-term registry, “CEDUR”
\n(Chronisch Entz\u00fcndliche Darmerkrankungen, Unabh\u00e4ngiges Register)<\/p>\n<\/div><\/div><\/div><\/div><\/div>

<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div><\/div>
[vc_custom_heading text=”Activities” use_theme_fonts=”yes”]

Measures to promote diagnostics and therapy of patients with severe chronic inflammatory diseases, in particular by:<\/strong><\/p>\n